Proper Level of Lipid Lowering with Pitavastatin and Ezetimibe in Acute Coronary Syndrome
Phase of Trial: Phase IV
Latest Information Update: 18 Apr 2017
At a glance
- Drugs Ezetimibe (Primary) ; Pitavastatin (Primary)
- Indications Acute coronary syndromes
- Focus Biomarker; Therapeutic Use
- Acronyms HIJ-PROPER
- 18 Apr 2017 Primary endpoint (Occurrence of any of the composite cardiovascular events) has not been met.
- 18 Apr 2017 Results published in the European Heart Journal
- 16 Nov 2016 Status changed from active, no longer recruiting to completed.